Clinical outcome details for 16 patients surviving ≥ 23 months including survival times (to follow-up at end 2010 or death) in months, disease sites at commencement of vaccination, treatments prior to commencement of vaccination and current status

Survival (Months)IDDisease sitesPrior TxStatus
121015s/c, LNS, RAlive, fully functional
117002S/C, lung, LNS, BAlive, fully functional
93010s/cS, ILIAlive, fully functional
76021s/cS, ILIAlive, fully functional
61031s/c, lung, LNS, RAlive, fully functional
44008s/cSDied
35049s/c, lungSAWD, fully functional
34050s/c, LN, brain, spleenR, SAlive, fully functional
34046s/c, lungSDied
33053s/c, lungSAlive, fully functional
29023S/C, GB, lungSDied
27052s/c, umbilicalSOff trial/died
26045s/cSDied
24006s/cSDied
24017s/c, LN, lung, liver, spleenSDied
23009S/C, Bone, lungS, RDied

Abbreviations: s/csub-cutaneous, LN lymph nodes, GB gall bladder, S surgery, B biological therapy, ILI isolated limb infusion (of chemotherapy), R radiotherapy, AWD alive with disease.